!

1)
!


,
30-90%. H

, (Boland
and al.,http://www.cancernetwork.
com/nurses/content/article/ 10165/1523565).

()
.

,

.

,

( C).

 ,
(
), ,
, ,
, .


.

,
, .



.
(http://www.onclive.com/publications/oncologynurse/2013/ June 2013)

:
1) , ,
.
2) ,
.
3)
, ,
( ).
4)
,

,
,.
5) .
6) ( ).
7) , .
8) (

o
).
9) .
10) .
11) .
12) ( ).
13)
( ),
( ).
14)
15) (
).


.
,
, ,
.

, .
, ,


.



.

,
(,
),
,
,
,


.


:
1) .
2)
( HIV).
3) (
).
4) ,
.
5)

6)
7) (
).

:
1) (cisplatin, carboplatin oxaliplatin).
2) (paclitaxel , docetaxel
cabazitaxel).
3) (vinblastine, vincristine,
vinorelbine etoposide).
4) (enalidomide pomalidomide).
5) (ixabepilone).
6) Bortezomib Carfilzomib
7) Eribulin

:
)

,



.
)
.
, SNRI, (),


.

8%
(Bhaskar et al., European Association for
palliative Care, Norway, June 7-9, 2012,posters
465 and 466) .

,

.


.

2
(www.mskcc.org/.../managing-chemotherapyinduced-peripheral-neurop).


.

(World Health
Organization, Eastern Cooperative Oncology
Group (ECOG), National Cancer Institute),
(Brief
Pain Inventory (BPI), Neuropathic Pain Scale

(NPS), FACT-taxane scale, Pain Quality

Assessment Scale (PQAS) ).



,

.
2)

, ,
60,
(varicella-herpes virus human
herpesvirus-3 (HHV-3).

.

. .
1.000.000
. 20%

(www.shinglessupport.org/.../professionalguidelines).


.
30-45 ,
, . 20%

,
.


,
, , .



(zoster sine herpete).

( ,
,
),

.



.

.

 .

. ,
,
,

.


.
.





.
,

.


.

TRPV1

.




wind
up. H
,

.

.

.
,
61%

zoster
sine herpete. MRI
.
,
(Herpes Simplex)
(emedicine.medscape.com/article/1143066overview).

.
:
2-3 (

famciclovir),
.

- (Zostavax),
60 ,

70%
(Neuropathic pain-pharmacological
management, NICE Clinical Guideline (March
2010).
:

,
8%

. 3
,
3
. H

C
(Chen JY, Chang CY, Feng PH, Chu CC,
So EC, Hu ML. Plasma vitamin C is lower in
postherpetic neuralgia patients and
administration of vitamin C reduces
spontaneous pain but not brush-evoked pain.
Clin J Pain. Sep 2009;25(7):562-9).
,

 ,

,
.
.
,
Cochrane Library,
(Chen N, Yang M, He L,
Zhang D, Zhou M, Zhu C (2010).
"Corticosteroids for preventing postherpetic
neuralgia". In He, Li. Cochrane Database
SystRev(12): CD005582.
doi:10.1002/14651858.CD005582.pub3. PMID
211 54361).


TENS (www.mayoclinic.com/health/postherpeticneuralgia).

3) HIV

HIV
,

 HIV
.
HIV



( GuillainBarre)

.
, (
10-30% ),



. ,


(www.ehealthme.com/cs/hiv+infection/neuralgia)
: , ,
, , ,

( ),

( ).
.


(didanosine, stavudine, zalcitabine
lamivudine),


60%.
,

,
B,
(emedicine.medscape.com/article/).


HIV (www.hopkinsmedicine.org).

,
,
, , .
8%

,
(Simpson DM, Brown S, Tobias J.
Controlled trial of high-concentration capsaicin
patch for treatment of painful HIV neuropathy.
Neurology. Jun 10 2008;70(24):2305-13).


.
4) ( 6)


,
,
,
.
,
,
,

.
,
.

,
,
,

, , ,
.

(, , ) ,
,
,
.


,
( ), (
, ),
,
.

(
, )
(
).

, ,
.

.



( 50
mg/).
,
, (;) .


(
6)



.


. 100 mg
,
.
5)



.
4,5 10.000 -
(Gaist D et al.,
Neurology 2002;58:1333-7).


(250
2010 ),

 .
,
,
, .



,
.
/
.



.
,
,
HMG Co-A reductase.

mevalonate .


.

Q10
(ubiquinone),
( )

 .

,
,
(Grundy SM et al., Circulation
2004; 110: 227-239).


.
H
)
, )
Q10 (ubiquinone), ) E,
B1 and B12 )
(Australian Adverse Drug Reactions Bulletin,
Volume 24, Number 2, April 2005).